vancomycin inhaled
Selected indexed studies
- Vancomycin. (, 2012) [PMID:31644188]
- Desensitization for inhaled vancomycin. (Ann Allergy Asthma Immunol, 2020) [PMID:32777433]
- Anaphylaxis. (Allergy Asthma Proc, 2019) [PMID:31690393]
_Worker-drafted node — pending editorial review._
Connections
vancomycin inhaled is a side effect of
Sources
- 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. (2016) pubmed
- Anthrax: an update. (2011) pubmed
- Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review. (2015) pubmed
- New Inhaled Antimicrobial Formulations for Use in the Cystic Fibrosis Patient Population. (2016) pubmed
- Vancomycin. (2012) pubmed
- Desensitization for inhaled vancomycin. (2020) pubmed
- Anaphylaxis. (2019) pubmed
- Pharmacokinetics of vancomycin in sputum of intubated patients: Optimized intravenous delivery vs. inhaled therapy. (2025) pubmed
- Phase I, Dose-Escalating Study of the Safety and Pharmacokinetics of Inhaled Dry-Powder Vancomycin (AeroVanc) in Volunteers and Patients with Cystic Fibrosis: a New Approach to Therapy for Methicillin-Resistant Staphylococcus aureus. (2020) pubmed
- Chapter 24: Anaphylaxis. (2012) pubmed